Abstract
A 76-year-old woman with atypical hemorrhagic Kaposi sarcoma is presented. The patient was treated with recombinant interferon alpha-2b (3,000,000 IU) subcutaneously, three times weekly for 6 months and twice weekly as maintenance dose for 14 months with excellent response and no recurrence after a 7 years of follow-up.
Copyright John Libbey Eurotext 2003.
MeSH terms
-
Aged
-
Biopsy, Needle
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Female
-
Follow-Up Studies
-
Hemorrhage / drug therapy
-
Hemorrhage / pathology
-
Humans
-
Immunohistochemistry
-
Injections, Subcutaneous
-
Interferon alpha-2
-
Interferon-alpha / administration & dosage*
-
Recombinant Proteins
-
Risk Assessment
-
Sarcoma, Kaposi / drug therapy*
-
Sarcoma, Kaposi / pathology*
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / pathology*
-
Treatment Outcome
Substances
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins